It has been a wild ride for some of the UK's biggest quoted companies over the past year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Dr Martens (LON:DOCS) will go fr...
|Type||Buy / Hold / Sell|
|Year End 31st Mar||Unit||2017||2018||2019||2020||2021||2022E||2023E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for DOCS
Economic uncertainty remains a major concern in many industry sectors. For investors in well known companies like Dr Martens (LON:DOCS), the question is: where will prices go from here? Dr Martens is part of an elite club of UK shares...
The Covid-19 crisis has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from here. These qu...
While the world continues to wrestle with the consequences of the Covid-19 pandemic, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as Dr Martens (LON:DOCS). Dr Martens is...
With areas of the economy continuing to recover from the impact of Covid, stock market investors have been laser-focused on the share prices of some of the UK’s biggest companies - including Dr Martens (LON:DOCS). Dr Martens is one of...
Dr. Martens plc is a United Kingdom-based company that designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company operates through three reporting segments: Europe, the Middle East and Africa (EMEA), Americas and Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes Originals, Fusion and Casual collections. It offers various accessories, such as shoe care, laces and socks, leather bags and small leather items. It operates in over 60 countries globally, through a range of modes: directly operated stores and ecommerce sites, wholesale partners and distributors.
Latest News for DOCS
Upcoming Events for DOCS
Full Year 2022 Dr Martens PLC Earnings Release
Q1 2023 Dr Martens PLC Trading Statement Release
Dr Martens PLC Annual Shareholders Meeting
As of Today at 13:06 UTC, shares in Dr Martens are trading at 199.40p. This share price information is delayed by 15 minutes.
Shares in Dr Martens last closed at 199.40p and the price had moved by -57.74% over the past 365 days. In terms of relative price strength the Dr Martens share price has underperformed the FTSE All Share Index by -58.58% over the past year.
The overall consensus recommendation for Dr Martens is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Dr Martens dividend yield is 0.61% based on the trailing twelve month period.
Last year, Dr Martens paid a total dividend of £0.01, and it currently has a trailing dividend yield of 0.61%. We do not have any data on when Dr Martens is to next pay dividends.
We do not have data on when Dr Martens is to next pay dividends. The historic dividend yield on Dr Martens shares is currently 0.61%.
To buy shares in Dr Martens you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 199.40p, shares in Dr Martens had a market capitalisation of £1.99bn.
Here are the trading details for Dr Martens:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: DOCS
Based on an overall assessment of its quality, value and momentum Dr Martens is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Dr Martens is 437.75p. That is 119.53% above the last closing price of 199.40p.
Analysts covering Dr Martens currently have a consensus Earnings Per Share (EPS) forecast of £0.16 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dr Martens. Over the past six months, its share price has underperformed the FTSE All Share Index by -48.6%.
As of the last closing price of 199.40p, shares in Dr Martens were trading -39.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Dr Martens PE ratio based on its reported earnings over the past 12 months is 10.55. The shares last closed at 199.40p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Dr Martens' management team is headed by:
- Paul Mason - NEC
- Kenny Wilson - CEO
- Jon Mortimore - CFO
- Emily Reichwald - GCN
- Tara Alhadeff - NED
- Ije Nwokorie - NID
- Robyn Perriss - NID
- Ian Rogers - NID
- Lynne Weedall - NID